17/10/2025 Strategic partnership with Uniphar Plc

NíoSync is proud to announce our strategic partnership with Uniphar, accelerating access to life-changing therapies for patients across Europe.

NíoSync is building Europe’s leading commercialisation platform for specialty biopharmaceutical products, designed to ensure that medical innovation reaches patients fairly, efficiently and at scale.

Through this collaboration, NíoSync gains immediate access to Uniphar Group's pan-European commercial infrastructure, accelerating the delivery of our first products and establishes the platform from which we will grow our portfolio. This partnership reflects a shared commitment to bringing innovative therapies to patients across Europe.

https://www.linkedin.com/posts/uniphargroup_elevating-access-to-specialty-therapies-is-activity-7384968657803853825-VtIz?utm_source=social_share_send&utm_medium=member_desktop_web&rcm=ACoAAAAV_K8BOPeZRErvuaDkj81jLXeT7GbflhI